Pancreatic Islet Cell Transplantation - A Novel Approach to Improve Islet Quality and Engraftment

PHASE1CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2017

Conditions
Islet Cell TransplantationType 1 Diabetes
Interventions
DRUG

Islet cell transplantation

The process is based on the enzymatic isolation of the pancreatic islets of Langerhans from an organ procured from a cadaveric donor; the islets obtained are injected into the liver of the recipient via percutaneous catheterization of the portal venous system . This procedure allows the selective transplantation of the insulin-producing cell population avoiding open surgery as well as the transplantation of the duodenum and the exocrine pancreas and their related morbidity.

Trial Locations (1)

75246

Annette C. & Harold C. Simmons Transplant Institute - Baylor University Medical Center, Dallas Texas, USA - Baylor All Saints Medical Center, Fort Worth Texas, USA, Dallas

Sponsors
All Listed Sponsors
collaborator

Baylor Health Care System

OTHER

lead

Baylor Research Institute

OTHER